EventsThe 6th International Electronic Conference on Applied Sciences
Published
This submission belongs to the session S2. Nanosciences, Chemistry and Materials Science of the event The 6th International Electronic Conference on Applied Sciences
Published date
03 Dec, 2025
Academic Editor
author-avatarAlberto Jiménez Suárez
Citation
yasser bouchebcheb, Aya Alem, sonochemical synthesis of benzothiazolinone schiff based derivative & ADME prediction study, in Proceedings of The 6th International Electronic Conference on Applied Sciences, 9 December–11 December 2025, MDPI: Basel, Switzerland
Share
Email
Facebook
Twitter
LinkedIn

sonochemical synthesis of benzothiazolinone schiff based derivative & ADME prediction study

1. Laboratory of Synthesis and Organic Biocatalysis (LSBO), Organic Synthesis and Medicinal Chemistry Group, Department Of Chemistry, Faculty of science, BADJI Mokhtar-Annaba University, P.O. Box 12, Annaba 23000, Algeria, Algeria
Abstract

Benzothiazolines are heterocyclic compounds that have been developed over time because they have important biological properties, according to the literature [1], with the goal of extending these properties and creating derivatives with multiple biological properties and functions [2,3].
Schiff bases are also physiologically active molecules with a range of characteristics, and researchers have been interested in discovering methods to synthesis Schiff bases.
In this study, we synthesized a Schiff base derivative benzothiazolone (E)-6-(((4-hydroxyphenyl)imino)methyl)-3-methylbenzo[d]thiazol-2(3H)-one , by the condensation reaction between 3-methyl-2-oxo-2,3-dihydrobenzo[d]thiazole-6-carbaldehyde (3) and primary aromatic amine, under ultrasound-assisted green conditions in ethanol, affording a 65% yield. Furthermore, an in-silico ADME analysis was performed using SwissADME online tools to evaluate the drug-likeness and pharmacokinetic behavior of the synthesized compound. The prediction revealed favorable pharmacokinetic properties,nd compliance with Lipinski’s rule of five, suggesting good oral bioavailability potential. These findings highlight the potential application of this compound in pharmaceutical development and support the green methodologies for obtaining bioactive heterocycles.

[1] M. Erdogan et al., “Design, synthesis and biological evaluation of new benzoxazolone/benzothiazolone derivatives as multi-target agents against Alzheimer’s disease,” European Journal of Medicinal Chemistry, vol. 212, p. 113124, Feb. 2021, doi: 10.1016/j.ejmech.2020.113124.

[2] S. H. Ferreira, B. B. Lorenzetti, M. Devissaguet, D. Lesieur, and Y. Tsouderos, “S14080, a peripheral analgesic acting by release of an endogenous circulating opioid‐like substance,” British J Pharmacology, vol. 114, no. 2, pp. 303–308, Jan. 1995, doi: 10.1111/j.1476-5381.1995.tb13227.x.

[3] N. Dharmaraj, P. Viswanathamurthi, and K. Natarajan, “Ruthenium(II) complexes containing bidentate Schi€ bases and their antifungal activity”.

Keywords
benzothiazolinone
Schiff bases
ADME study
ultrasound
green chemistry.
Poster
Yasser BOUCHEBCHEB Poster.pdf
Comparison of the effects of traditional pasteurization, HTST and UHT on phenolic compounds in strawberry-chokeberry and strawberry-blackcurrant nectars during cold storage

Optimizing Sour Beer Production Through High-Temperature and Glucose Supplementation with Mixed Culture Fermentation of Kveik and Lachancea thermotolerans Yeast Strains